
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[TXG] 10x Genomics Inc - Cl. A Cashflow Statement
Data updated 2024-Mar-24 (Sunday)Note: Easy to read Cashflow Statement for 10x Genomics Inc - Cl. A [NASDAQ:TXG] with charts that analyze trends of statement items & metrics and compare them with peers
Share
View Financial Statements & visualize data for other stocks
Choose statement type
Choose statement frequency
Quarterly Cashflow Statement values for 10x Genomics Inc - Cl. A are rounded to enhance readability. Hover on cells below for additional contextual info. Key metrics are also provided for your convenience
2023-Dec | 2023-Sep | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | |
---|---|---|---|---|---|---|
Net Income Detail | -255 M | -93 M | -62.4 M | -50.7 M | -17.2 M | -41.9 M |
Depreciation & Amortization Detail | 35.5 M | 11.4 M | 11.9 M | 8.62 M | 8.47 M | 8.12 M |
Taxes Detail | - | - | - | - | - | - |
Working Capital Detail | -8.76 M | 16.2 M | -9.93 M | -5.96 M | -19.3 M | -9.94 M |
Other Operating Detail | 213 M | 40.1 M | 48.9 M | 44 M | 41.8 M | 34.2 M |
Operating Cash Flow Detail | -15.2 M | -25.3 M | -11.5 M | -4.13 M | 13.7 M | -9.56 M |
Operating Cash Flow / Sales Detail | -8.3% | -16.5% | -7.9% | -3.1% | 8.8% | -7.3% |
Cash EPS Detail | -0.13 | -0.21 | -0.1 | -0.04 | 0.12 | -0.08 |
Capital Expenditure Detail | -48.6 M | -15.4 M | -25.4 M | -5.28 M | -39.7 M | -36.6 M |
Investments Detail | 183 M | 20.3 M | 20.9 M | 125 M | 9.06 M | 5.44 M |
Acquisitions Detail | - | - | - | - | -2.5 M | -1.5 M |
Other Investing Detail | -923 K | - | - | - | - | - |
Investing Cash Flow Detail | 133 M | 4.9 M | -4.46 M | 120 M | -33.2 M | -32.6 M |
Investing Cash Flow / Sales Detail | 72.6% | 3.2% | -3.0% | 89.3% | -21.2% | -24.9% |
Dividend Detail | - | - | - | - | - | - |
Stock Detail | - | 4.37 M | 7.1 M | 2.4 M | 5 M | 2.04 M |
Debt Detail | - | - | - | -5.81 M | - | - |
Other Financing Detail | 13.7 M | - | - | - | - | - |
Financing Cash Flow Detail | 13.7 M | 4.37 M | 7.1 M | -3.41 M | 5 M | 2.04 M |
Financing Cash Flow / Sales Detail | 7.4% | 2.9% | 4.8% | -2.5% | 3.2% | 1.6% |
Net Change in Cash Detail | 132 M | -16.1 M | -8.94 M | 112 M | -14.2 M | -40.2 M |
Free Cash Flow Detail | 33.4 M | -40.5 M | -36.9 M | -8.68 M | -26 M | -46.1 M |
FCF / Share Detail | 0.28 | -0.34 | -0.32 | -0.08 | -0.23 | -0.4 |
Chart shows absolute values of Net Income using quarterly statements for 10x Genomics Inc - Cl. A. Fiscal Dates standardized to enable peer comparisons
Select Cashflow Statement line/metric for chart. Other fields & statement line items available when different statement type selected
Subsequent stock performance post quarterly earnings date till next announcement for 10x Genomics Inc - Cl. A. Dates correspond to earnings announcement dates for the period when new financial data became available to the market. Prices have been adjusted for any splits
Related to 10x Genomics Inc - Cl. A
Information for 10x Genomics Inc - Cl. A
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-05 on Google
SEC Reports : Quarterly reports around 2025-May-05 on SEC Edgar
Compare 10x Genomics Inc - Cl. A with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes 10x Genomics Inc - Cl. A
Industry : Equipment & Supplies industry performance which includes 10x Genomics Inc - Cl. A